Dr Cassandra Kelly-Cirino

Dr. Cassandra Kelly-Cirino has over a decade of experience as a senior executive in non-profit, research, private, and public health settings globally, and is a recognized diagnostics expert across multiple diseases areas spanning research and development, evaluation, validation, implementation, market access, and regulatory aspects. She began her career at the Canadian National Microbiology Laboratory focused on emerging infections, then spent a decade at the Wadsworth Center in Albany, New York as Deputy Director of the Biodefense Laboratory, followed by a 5-year period as Vice President, Infectious Diseases for DNA Genotek/OraSure Technologies. Most recently, Dr. Kelly-Cirino led a newly formed team at the Foundation for Innovative New Diagnostics (FIND) as Director of Emerging Threats focused on the development of innovative diagnostic technologies to support countries in Africa and South East Asia to detect and respond to emerging infections endemic in their regions. In her role as Senior Director for Innovation and New Technology at the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Dr. Kelly-Cirino oversees EGPAF’s innovation portfolio including introduction of new treatments, models of care and diagnostics across EGPAF’s vast implementation platform. Dr. Kelly-Cirino holds a Ph.D. in Immunology and Infectious Disease from the State University of New York, Albany.